Chris Cargill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MOUNTAIN STATES POLICY CENTER: This thought experiment defines the current health care system in the United States.

MOUNTAIN STATES POLICY CENTER: Government officials have been placed on notice by the U.S. Supreme Court (SCOTUS) concerning undue impact fees.

Nxera Pharma in Cambridge and Tokyo - formerly Sosei Heptares – has joined the World Orphan Drug Alliance (WODA), a global cohort of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in complex markets around the world.

Japan, South Korea, and the African subcontinent are now covered by the Alliance. With the addition of two new WODA members – Nxera Pharma (formerly Sosei Heptares) and Veld Pharmaceuticals – WODA now provides access to over 200 million rare disease patients. TOKYO and ZUG, Switzerland, April 08, 2024 (GLOBE NEWSWIRE) -- The World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in comp

Tokyo, Japan and Cambridge, UK, 3 April 2024 - Nxera Pharma (“Nxera” or “the Company”; TSE: 4565) – formerly known as Sosei Group or Sosei Heptares – today announces the appointment of Japan pharmaceutical sector expert, Mr. Patrick Branch, as Head of Business Development for Japan and the APAC region. Mr. Branch will join Nxera’s global Business Development team that is led by Dr. Marcus Messenger. He will be based in Nxera’s Tokyo office and will oversee Japan and regional disease area strateg